Adenine nucleotides act through specific cell surface receptors to invoke a variety of biological responses. Here we show that cells of neuroepithelial bodies (NEB), presumed O2 airway sensors in neonatal hamster lung, express functional P2X receptors (P2X-R). Positive immunostaining was detected in NEB cells using double-label immunohistochemistry with antibodies against P2X2 and P2X3 receptor subunits, which co-localized with serotonin (5-HT), a marker of NEB cells. For electrophysiological characterization of P2X2-R in NEB cells, fresh neonatal hamster lung slice preparation was used. Under whole-cell patch clamp, perfusion with ATP induced a concentration-dependent, non-desensitizing inward current (EC50=12 microM). Perfusion with alpha,beta-methylene ATP also induced a slow-desensitizing inward current (EC50=8.2 microM). Suramin (IC50 ca. 43 microM) and TNP-ATP (IC50 ca. 8 microM) blocked the currents evoked by both ATP and alpha,beta-methylene ATP. Using carbon fiber amperometry we observed that hypoxia and ATP induced 5-HT release from NEB cells and that this release was blocked by suramin. These data suggest that functional P2X2/3 heteromeric receptors are expressed in NEB cells. The possible function of these purinoreceptors in NEB cells could include modulation of hypoxia chemotransmission.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1515/BC.2004.022 | DOI Listing |
Nanoscale
December 2024
State Key Laboratory of Silicon and Advanced Semiconductor Materials, School of Materials Science and Engineering, Zhejiang University, Hangzhou, Zhejiang 310058, China.
Exotic polar topologies such as polar skyrmions have been widely observed in ferroelectric superlattice systems. The dynamic motion of polar skyrmions under external forces holds promise for applications in advanced electronic devices such as race-track memory. Meanwhile, the polar skyrmion motion has proven to be challenging due to the strong skyrmion-skyrmion interaction and a lack of a mechanism similar to the spin-transfer torque.
View Article and Find Full Text PDFImmunotargets Ther
November 2024
Goethe University Frankfurt, Department of Anaesthesiology, Intensive Care Medicine, and Pain Therapy, University Hospital Frankfurt, Frankfurt, 60590, Germany.
Background: COVID-19 is a serious viral infection, which is often associated with a lethal outcome. Therefore, understanding mechanisms, which affect the immune response during SARS-CoV2 infection, are important.
Methods: To address this, we determined the number of T cells in peripheral blood derived from intensive care COVID-19 patients.
Proc Natl Acad Sci U S A
November 2024
Cell and Molecular Biology Graduate Program, Colorado State University, Fort Collins, CO 80523.
Ribosome structure and activity are challenged at high temperatures, often demanding modifications to ribosomal RNAs (rRNAs) to retain translation fidelity. LC-MS/MS, bisulfite-sequencing, and high-resolution cryo-EM structures of the archaeal ribosome identified an RNA modification, 4,4-dimethylcytidine (mC), at the universally conserved C918 in the 16S rRNA helix 31 loop. Here, we characterize and structurally resolve a class of RNA methyltransferase that generates mC whose function is critical for hyperthermophilic growth.
View Article and Find Full Text PDFChem Rev
November 2024
School of Computer, Data and Mathematical Sciences, Western Sydney University, Penrith, New South Wales 2752, Australia.
Protein Expr Purif
February 2025
Talwar Research Foundation, E-8, Neb Valley, New Delhi, 110068, India. Electronic address:
Survivin is an inhibitor of apoptosis, and expressed in a large number of cancers. As Survivin expression is very low in normal tissues, it assumes significance as a prominent target for tumor diagnosis, prognosis and developing anti-cancer therapies. We report development of a novel triple fusion protein for a prospective vaccine against Survivin in targeted cancer immunotherapy.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!